Back to funds

Rhenman & Partners Asset Management AB

hedge fundUpdated 10 days ago

Managed by Rhenman & Partners Asset Management Ab • Latest filing Q3 2026

Portfolio value
$902.9M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$1.1B
Q1 2026$810.5M
Q2 2026$1.1B
Q3 2026$902.9M

Top holdings

93 positions as of Q3 2026

View filing
J

IOVANCE BIOTHERAPEUTICS INC

Value
$37.1M
Shares
2.50M
% Port
4.11%
A

ASTRAZENECA PLC

Value
$30.3M
Shares
185.0K
% Port
3.35%
M

MERCK & CO. INC

Value
$30.1M
Shares
206.9K
% Port
3.33%
M

MEDTRONIC PLC

Value
$29.3M
Shares
340.0K
% Port
3.25%
U

UNITEDHEALTH GROUP INC

Value
$26.2M
Shares
71.4K
% Port
2.90%
V

VERTEX PHARMACEUTICALS INC

Value
$25.6M
Shares
48.9K
% Port
2.83%
G

GILEAD SCIENCES INC

Value
$23.7M
Shares
159.1K
% Port
2.63%
E

EDWARDS LIFESCIENCES CORP

Value
$23.6M
Shares
273.0K
% Port
2.61%
B

BIOMARIN PHARMACEUTICAL INC

Value
$23.2M
Shares
386.9K
% Port
2.57%
B

BIOGEN INC

Value
$21.9M
Shares
97.0K
% Port
2.43%
L

ELI LILLY & CO

Value
$21.8M
Shares
18.9K
% Port
2.42%
I

INSMED INC

Value
$21.4M
Shares
187.1K
% Port
2.36%
C

CVS HEALTH CORP

Value
$18.9M
Shares
220.4K
% Port
2.09%
C

CENCORA INC

Value
$18.8M
Shares
62.5K
% Port
2.08%
A

AXSOME THERAPEUTICS INC.

Value
$18M
Shares
97.7K
% Port
2.00%
A

ABBVIE INC

Value
$16.1M
Shares
61.6K
% Port
1.79%
J

JAZZ PHARMACEUTICALS PLC

Value
$15.7M
Shares
67.8K
% Port
1.74%
J

JOHNSON & JOHNSON

Value
$15.5M
Shares
58.5K
% Port
1.72%
M

MCKESSON CORP

Value
$15.2M
Shares
17.9K
% Port
1.69%
D

DANAHER CORP DEL

Value
$15.2M
Shares
68.5K
% Port
1.68%

Explore